<DOC>
	<DOCNO>NCT02074462</DOCNO>
	<brief_summary>Voriconazole broad-spectrum antifungal agent . There evidence relation efficacy safety voriconazole voriconazole trough concentration . There several factor could influence voriconazole concentration . Inflammation could one factor . In retrospective study observe reduced metabolism voriconazole related inflammation patient severe infection . Reduced metabolism voriconazole result high voriconazole level low N-oxide metabolite ( inactive metabolite voriconazole ) level . The purpose study determine algorithm guide dose voriconazole severe inflammation develop multiple linear regression model describe contribution CRP concentration variability voriconazole level metabolic ratio .</brief_summary>
	<brief_title>Effect Inflammation Voriconazole Concentration</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>age â‰¥ 18 yr treatment voriconazole write informed consent concomitantly use strong inhibitor inducer CYP P450</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Voriconazole</keyword>
	<keyword>CRP</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>